Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Recruiting · Phase 2 · NCT05571059
Conditions: Idiopathic Pulmonary Fibrosis
At a glance
- Research payments reported, 2025
- $529,985
- U.S. investigators named
- 13
- Sites paid
- 13
- Planned or actual enrollment
- 128
About the trial
- Sponsor
- Cumberland Pharmaceuticals
- Tested
- Ifetroban Sodium (drug), Placebo (drug)
- Dates
- Started 2024-01-31; completion 2028-01
- Results posted
- Not yet
Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF.
From ClinicalTrials.gov, last updated 2026-09-02. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Cumberland Pharmaceuticals, Inc. reported $529,985 in research payments for this study in 2025 (61 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Robert M. Jackson, MD Pulmonology · Miami, FL
- Augustine Lee, MD Pulmonology · Jacksonville, FL
- Damien G. Patel, MD Critical Care Medicine · Indianapolis, IN
- Mark J. Hamblin, MD Pulmonology · Kansas City, KS
- Girish Nair, MD Pulmonology · Lexington, KY
- Mohamed Saad, MD Pulmonology · Louisville, KY
- Maria L. Padilla, MD Pulmonology · New York, NY
- Jeremy P. Feldman, M.D. Pulmonology · Bend, OR
- Gerard Criner, MD Pulmonology · Philadelphia, PA
- Fady G. Jamous, M.D. Pulmonology · Sioux Falls, SD
- Mohammad A. Alsoub, MD Pulmonology · Dickson, TN
- Sanober Kable, MD Pulmonology · Denison, TX
- Susan K. Mathai, M.D. Pulmonology · Dallas, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Kumc Research Institute Inc $107,319
- Bend Memorial Clinic $96,490
- Indiana University Health Inc $59,817
- Baylor Research Institute $59,103
- Temple Univ of the Commonwealth System of Higher Education $39,361
- Avera Mckennan $35,667
- Premier Pulmonary Critical Care & Sleep Medicine $33,079
- University of Louisville Research Foundation $30,339
- Pulmonary & Sleep Specialists PLLC $29,655
- S Fl Veterans Affairs Foundation for Research & Education Inc $14,939
- Mount Sinai School of Medicine $12,366
- Mayo Clinic, FL $8,350
- William Beaumont Hospital $3,500
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.